Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 682 K520 K556 K585 K723 K 2.38 M Research & development ————— — Operating income 3.68 M-214 K4.49 M12.12 M13 M 29.39 M Non-Operating Income, Total 11.43 M-7.66 M-2.41 M-7.9 M-4.26 M -22.23 M Interest expense, net of interest capitalized 5.18 M4.98 M4.85 M5.02 M4.72 M 19.57 M Non-Operating Income, excl. Interest Expenses 11.43 M-7.66 M-2.41 M-7.9 M-4.26 M -22.23 M Unusual income/expense 1.95 M267 K79 K210 K1.46 M 2.01 M Pretax income 9.93 M-12.85 M-2.76 M-809 K14.95 M -1.48 M Equity in earnings -136 K-50 K58 K102 K-191 K -81 K Taxes ————0 — Non-controlling/minority interest 0———— — After tax other income/expense ————— — Net income before discontinued operations 15.11 M-7.88 M2.09 M4.21 M-4.3 M -5.88 M Discontinued operations ————— — Net income 15.11 M-7.88 M2.09 M4.21 M-4.3 M -5.88 M Dilution adjustment 755 K755 K755 K754 K243 K 2.51 M Preferred dividends 6.76 M6.76 M6.76 M6.76 M5.92 M 26.2 M Diluted net income available to common stockholders 9.11 M-13.88 M-3.92 M-1.79 M-9.98 M -29.57 M Basic earnings per share (Basic EPS) 0.25-0.38-0.11-0.05-0.24 -0.78 Diluted earnings per share (Diluted EPS) 0.25-0.38-0.11-0.05-0.24 -0.78 Average basic shares outstanding 36.18 M36.18 M36.19 M36.51 M40.86 M — Diluted shares outstanding 36.18 M36.18 M36.19 M36.51 M40.86 M — EBITDA 12.11 M8.16 M12.89 M21.47 M23.37 M 65.88 M EBIT 3.68 M-214 K4.49 M12.12 M13 M 29.39 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 8.43 M8.37 M8.39 M9.35 M10.37 M 36.49 M